SCHEMBL1763543

SCHEMBL1763543

O=C(O)c1ccc(C2=CCN(C(=O)O)CC2)c(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 1/20 0.41
TRPV1 Q8NER1 5/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MAPT P10636 1/20 0.40
TTR P02766 1/20 0.39
RARB P10826 2/20 0.38
SRD5A2 P31213 1/20 0.37
RARA P10276 1/20 0.36
RARG P13631 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PPARG P37231 1/20 0.36
RORC P51449 1/20 0.36
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1840656 0.87 NOTUM (0.44) TRPV1MMP2MMP3MAPTNPC1
SCHEMBL28437327 0.86 MAPT (0.43) TRPV1MMP2MMP3MAPTL3MBTL1
SCHEMBL1764228 0.85 PDK4 (0.52) RORC
SCHEMBL28909629 0.85 TSHR (0.46) TRPV1MMP2MMP3MAPTL3MBTL1
SCHEMBL3325476 0.82 MAPT (0.50) TRPV1MMP2MMP3MAPTL3MBTL1
SCHEMBL28438757 0.79 TRPV1 (0.44) TRPV1MAPTNPC1ALDH1A1ALOX15
SCHEMBL24860779 0.78 PDE3B (0.47) ADH5TTRRARBSRD5A2AKR1C3
SCHEMBL28433071 0.78 TRPV1 (0.45) TRPV1MAPTMEN1KMT2AALDH1A1
SCHEMBL2936346 0.76 PDE3B (0.44) ADH5TTRRARBSRD5A2PPARG
Hydrochloric Acid SCHEMBL9229512 0.76 ADH5 (0.52) ADH5MAPTTTRRARBSRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118262-A1 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed
EP-2321274-A1 PYRROLIDINYL AND PIPERIDINYL COMPOUNDS USEFUL AS NHE-1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2011-05-18 EP disclosed
WO-2010005783-A1 PYRROLIDINYL AND PIPERIDINYL COMPOUNDS USEFUL AS NHE-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118262-A1 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors NHERF1, SLC9A1, SLC9A5 ADH5 420/4885TRPV1 228/4885MMP2 782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.